Northrop Grumman
NOC
473.46
-9.65
-2.00%
Northrop Grumman
US · NOC
#317 by market cap
Listed 1970
473.46
-9.65
-2.00%
Live - 5344 symbols - heartbeat 506s ago
· 2026-10-08 08:07
Pre-market
474.83
+0.29%
After-hours
475.60
+0.45%
Overnight
472.43
-0.22%
- Market cap
- 67.26B
- P/E (TTM)i
- 15.05
- P/Bi
- 3.76
- EPSi
- 29.08
- Div yieldi
- 1.99%
- 52W posi
- 1%
Reader sentiment
Are you bullish or bearish on NOC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.74, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +2.24% YoY
Margins
- Gross margin
- 19.81%
- Operating margin
- 10.20%
- Net margin
- 9.97%
Key ratios & quality
- Altman Z-Scorei
- 2.74
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 30.10B | 33.84B | 36.80B | 35.67B | 36.60B | 39.29B | 41.03B | 41.95B |
| Gross profit | 6.79B | 7.26B | 7.48B | 7.27B | 7.47B | 6.55B | 8.36B | 8.31B |
| Selling & admin expenses | 3.01B | 3.29B | 3.41B | 3.60B | 3.87B | 4.01B | 3.99B | 4.03B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 3.78B | 3.97B | 4.07B | 3.67B | 3.60B | 2.54B | 4.37B | 4.28B |
| Pretax profit | 3.74B | 2.55B | 3.73B | 8.94B | 5.84B | 2.35B | 5.02B | 5.07B |
| Tax | 513.00M | 300.00M | 539.00M | 1.93B | 940.00M | 290.00M | 842.00M | 886.00M |
| Net profit | 3.23B | 2.25B | 3.19B | 7.01B | 4.90B | 2.06B | 4.17B | 4.18B |
| Basic EPS | 19 | 13 | 19 | 44 | 32 | 14 | 28 | 29 |
| Diluted EPS | 18.49 | 13.22 | 19.03 | 43.54 | 31.47 | 13.53 | 28.34 | 29.08 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 9.47B | 10.35B | 10.42B | 11.71B | 9.88B | 10.88B |
| Gross profit | 1.58B | 2.21B | 2.23B | 2.30B | 1.96B | 2.12B |
| Selling & admin expenses | 1.01B | 1.02B | 985.00M | 1.03B | 971.00M | 1.03B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 573.00M | 1.19B | 1.24B | 1.27B | 989.00M | 1.10B |
| Pretax profit | 578.00M | 1.43B | 1.32B | 1.74B | 1.03B | 1.17B |
| Tax | 97.00M | 253.00M | 223.00M | 313.00M | 155.00M | 74.00M |
| Net profit | 481.00M | 1.17B | 1.10B | 1.43B | 875.00M | 1.09B |
| Basic EPS | 3 | 8 | 8 | 10 | 6 | 8 |
| Diluted EPS | 3.32 | 8.15 | 7.67 | 9.96 | 6.14 | 7.68 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 9.68B | 10.69B | 15.34B | 12.43B | 12.49B | 13.71B | 14.27B | 15.29B |
| Cash & ST investments | 1.58B | 2.25B | 4.91B | 3.53B | 2.58B | 3.11B | 4.35B | 4.40B |
| Inventory | 654.00M | 783.00M | 759.00M | 811.00M | 978.00M | 1.11B | 1.46B | 1.31B |
| Total assets | 37.65B | 41.09B | 44.47B | 42.58B | 43.76B | 46.54B | 49.36B | 51.38B |
| Total current liabilities | 8.27B | 9.43B | 9.58B | 9.53B | 11.59B | 11.94B | 14.13B | 13.88B |
| Short-term debt | 517.00M | 1.11B | 742.00M | 6.00M | -- | -- | -- | -- |
| Long-term debt | 13.88B | 12.77B | 14.26B | 12.78B | 11.81B | 13.79B | 14.69B | 15.16B |
| Total liabilities | 29,466,000,000.00 | 32,270,000,000.00 | 33,890,000,000.00 | 29,653,000,000.00 | 28,443,000,000.00 | 31,749,000,000.00 | 34,069,000,000.00 | 34,703,000,000.00 |
| Total equity | 8.19B | 8.82B | 10.58B | 12.93B | 15.31B | 14.80B | 15.29B | 16.67B |
| Retained earnings | 8.07B | 8.75B | 10.48B | 12.91B | 15.31B | 14.77B | 15.30B | 16.66B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 13.27B | 14.03B | 14.11B | 15.29B | 14.77B | 15.59B |
| Cash & ST investments | 1.69B | 1.90B | 1.96B | 4.40B | 2.09B | 2.31B |
| Inventory | 1.58B | 1.55B | 1.62B | 1.31B | 1.45B | 1.42B |
| Total assets | 48.47B | 49.45B | 49.30B | 51.38B | 50.01B | 50.76B |
| Total current liabilities | 13.97B | 13.46B | 12.72B | 13.88B | 12.82B | 13.35B |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | 14.17B | 15.16B | 15.16B | 15.16B | 14.41B | 14.43B |
| Total liabilities | 33,484,000,000.00 | 33,980,000,000.00 | 33,312,000,000.00 | 34,703,000,000.00 | 32,892,000,000.00 | 32,879,000,000.00 |
| Total equity | 14.98B | 15.47B | 15.99B | 16.67B | 17.12B | 17.88B |
| Retained earnings | 14.98B | 15.45B | 15.97B | 16.66B | 17.10B | 17.84B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3.83B | 4.30B | 4.31B | 3.57B | 2.90B | 3.88B | 4.39B | 4.76B |
| Depreciation & amortization | 800.00M | 1.27B | 1.27B | 1.24B | 1.34B | 1.34B | 1.37B | 1.47B |
| Free cash flow | 2.58B | 3.03B | 2.89B | 2.15B | 1.47B | 2.10B | 2.62B | 3.31B |
| Dividends paid | -821.00M | -880.00M | -953.00M | -983.00M | -1.05B | -1.12B | -1.19B | -1.29B |
| Stock buybacks / issuance | -1.26B | -744.00M | -490.00M | -3.71B | -1.50B | -1.50B | -2.51B | -1.62B |
| Ending cash balance | 1.58B | 2.25B | 4.91B | 3.53B | 2.58B | 3.11B | 4.35B | 4.40B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -1.57B | 868.00M | 1.56B | 3.90B | -1.66B | 1.28B |
| Depreciation & amortization | 337.00M | 350.00M | 379.00M | 406.00M | 372.00M | 367.00M |
| Free cash flow | -1.82B | 637.00M | 1.26B | 3.24B | -1.82B | 978.00M |
| Dividends paid | -302.00M | -332.00M | -330.00M | -329.00M | -333.00M | -351.00M |
| Stock buybacks / issuance | -480.00M | -411.00M | -277.00M | -456.00M | -68.00M | 0 |
| Ending cash balance | 1.69B | 1.90B | 1.96B | 4.40B | 2.09B | 2.31B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 42.39 | 26.44 | 32.88 | 59.60 | 34.68 | 13.66 | 27.75 | 26.17 |
| ROA %i | 8.90 | 5.71 | 7.45 | 16.09 | 11.34 | 4.55 | 8.70 | 8.30 |
| ROIC %i | 17.07 | 11.50 | 14.51 | 27.45 | 18.57 | 8.53 | 15.07 | 14.45 |
| 5-year avg ROE %i | 36.15 | 36.80 | 37.14 | 41.48 | 39.15 | 33.45 | 33.71 | 32.37 |
| EBIT margin %i | 14.30 | 9.09 | 11.74 | 26.62 | 17.33 | 7.36 | 13.74 | 13.67 |
| FCF / sales %i | 8.57 | 8.96 | 7.84 | 6.03 | 4.01 | 5.34 | 6.39 | 7.88 |
| Current ratioi | 1.17 | 1.13 | 1.60 | 1.30 | 1.08 | 1.15 | 1.01 | 1.10 |
| Quick ratioi | 0.97 | 0.94 | 1.21 | 1.10 | 0.87 | 0.86 | 0.82 | 0.89 |
| Debt / assetsi | 38.24 | 36.96 | 36.76 | 33.76 | 31.15 | 33.68 | 33.41 | 33.13 |
| LT debt / equityi | 169.57 | 159.63 | 147.50 | 111.15 | 89.01 | 105.97 | 107.85 | 102.07 |
| Interest coveragei | 7.66 | 5.83 | 7.29 | 17.08 | 12.53 | 5.30 | 9.08 | 8.62 |
| Revenue CAGR (3Y) %i | 8.55 | 11.06 | 12.27 | 5.83 | 2.65 | 2.21 | 4.78 | 4.65 |
| Net income CAGR (3Y) %i | 17.51 | 3.24 | 3.59 | 29.45 | 29.62 | -13.61 | -15.85 | -5.12 |
| FCF CAGR (3Y) %i | 15.09 | 17.01 | 19.63 | -5.84 | -21.52 | -10.05 | 6.79 | 31.15 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 25.41 | 26.50 | 26.15 | 26.17 | 28.51 | 26.96 |
| ROA %i | 7.71 | 8.12 | 8.24 | 8.30 | 9.29 | 8.97 |
| ROIC %i | 13.71 | 14.17 | 14.19 | 14.45 | 15.93 | 15.19 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 12.62 | 13.32 | 13.51 | 13.67 | 14.61 | 13.80 |
| FCF / sales %i | 4.40 | 3.23 | 4.48 | 7.88 | 7.80 | 8.50 |
| Current ratioi | 0.95 | 1.04 | 1.11 | 1.10 | 1.15 | 1.17 |
| Quick ratioi | 0.74 | 0.83 | 0.86 | 0.89 | 0.89 | 0.94 |
| Debt / assetsi | 33.05 | 34.31 | 34.40 | 33.13 | 32.63 | 32.09 |
| LT debt / equityi | 106.92 | 109.66 | 106.07 | 102.07 | 95.33 | 91.08 |
| Interest coveragei | 8.07 | 8.30 | 8.51 | 8.62 | 9.23 | 8.98 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Aeronautics Systems is the largest reported line at 32.36% of revenue, across 6 reported segments.
- No single line clears half of revenue; Mission Systems is next at 29.88%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Aeronautics Systems32.36%
Mission Systems29.88%
Space Systems25.31%
Defense Systems19.24%
Quote time 2026-10-08 08:07:36 · For reference only, not investment advice and not tailored to your situation.